Home › Funds › JB Capital LLC › CROX
JB Capital LLC position in CROX
CROCS INC · Consumer Discretionary
JB Capital LLC reported holding 59,711 shares of CROX (CROCS INC) in its Q3 2026 13F filing — a position valued at US$7.0M, representing 0.24% of its reported portfolio and ranking #49 among its reported holdings. JB Capital LLC has disclosed CROX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How JB Capital LLC's CROX position evolved
JB Capital LLC first disclosed a stake in CROX in Q3 2023 at 7,124 shares (US$629K). The position peaked in Q2 2026 at 59,472 shares, worth US$7.2M. Across 13 filings, JB Capital LLC increased the stake 10 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 59,711 shares valued at US$7.0M. Notable position changes include a 33% increase in Q4 2023 (shares rose 54% over the following quarter), a 31% increase in Q3 2025 (shares rose 1% over the following quarter), a 113% increase in Q1 2026 (shares rose 46% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 7.12K | $628.55K | New |
| Q4 2023 | 9.51K | $887.93K | Add |
| Q1 2024 | 10.82K | $1.56M | Add |
| Q2 2024 | 11.60K | $1.69M | Add |
| Q3 2024 | 10.97K | $1.59M | Reduce |
| Q4 2024 | 12.41K | $1.36M | Add |
| Q1 2025 | 15.80K | $1.68M | Add |
| Q2 2025 | 16.39K | $1.66M | Add |
| Q3 2025 | 21.55K | $1.80M | Add |
| Q4 2025 | 26.18K | $2.24M | Add |
| Q1 2026 | 55.87K | $4.64M | Add |
| Q2 2026 | 59.47K | $7.17M | Add |
| Q3 2026 | 59.71K | $7.00M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CROX and 13F data
CROX (CROCS INC) is a Consumer Discretionary company. 30 other funds we track also report a position in CROX — the largest reported positions include Himalaya Capital (US$107.0M), No Street GP LP (US$98.9M), Patient Capital Management, LLC (US$96.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CROX
- Himalaya Capital 887.09K sh · $107.02M · Q2 2026
- No Street GP LP 820.00K sh · $98.92M · Q2 2026
- Patient Capital Management, LLC 799.43K sh · $96.44M · Q2 2026
- Smead Capital Management, Inc. 709.82K sh · $83.27M · Q3 2026
- DME Capital Management, LP 669.14K sh · $80.73M · Q2 2026
- WIT Partners Advisory Pte. Ltd. 632.81K sh · $74.24M · Q3 2026
- Evercore Wealth Management, LLC 594.86K sh · $71.76M · Q2 2026
- Punch Card Management L.P. 577.17K sh · $69.63M · Q2 2026
More on JB Capital LLC
FAQ
How long has JB Capital LLC held CROX?
JB Capital LLC has disclosed CROX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is JB Capital LLC's current position in CROX?
As of Q3 2026, JB Capital LLC holds 59.71K shares of CROX (CROCS INC), valued at $7.00M, representing 0.24% of its reported portfolio and ranking #49.
Has JB Capital LLC been buying or selling CROX?
In the latest 13F filing (Q3 2026), JB Capital LLC held unchanged its position in CROX. The position peaked in Q2 2026 at 59.47K shares.
Which other funds hold CROX?
Other major institutional holders of CROX include Himalaya Capital, No Street GP LP, Patient Capital Management, LLC, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.